David LaPre - 01 Jan 2024 Form 3 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)

Role
Director
Signature
/s/ Wendy Pizarro, Attorney-in-fact for David LaPre
Issuer symbol
CLDI
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
3
Filing time
12 Mar 2024, 20:00:37 UTC
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"David LaPre filed Form 3 for Calidi Biotherapeutics, Inc. (CLDI) on 12 Mar 2024."

Quick Takeaways

  • This page summarizes David LaPre's Form 3 filing for Calidi Biotherapeutics, Inc. (CLDI).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 12 Mar 2024, 20:00.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney

Sponsored